|Bid||55.00 x 1200|
|Ask||80.00 x 2200|
|Day's Range||71.85 - 72.75|
|52 Week Range||52.51 - 80.71|
|PE Ratio (TTM)||34.29|
|Earnings Date||Jul 30, 2018 - Aug 3, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||79.72|
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.
DaVita Inc (NYSE:DVA) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. With many analysts covering the large-cap stock, we mayRead More...
NEW YORK, June 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of PPL ...
The firm was among several potential buyers including large retailers, strategic health-care partners and venture-capital and private equity firms.
NEA has acquired DaVita's primary care business, Paladina Health. The Silicon Valley venture fund with more than $3 million under management occasionally acquires majority positions in companies when it sees a big opportunity. New Enterprise Associates, the Silicon Valley venture firm with a massive $3 billion under management, has acquired DaVita' DVA s chain of primary care clinics, Paladina Health , for around $100 million.
CHICAGO, June 6, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (DVA), a leading provider of kidney care services in the United States, and the University of Chicago Medicine today announced the successful implementation of the Transplant Waitlist Support Program, which was created to help keep waitlisted patients transplant-ready by proactively and electronically exchanging patient information between DaVita and the transplant center.
With Morgan Stanley calling clinical laboratory services market a safe haven, let's find out what's working in favor and against this burgeoning niche market.
DENVER , May 29, 2018 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States , released its "Today's Kidney Diet: ...
Stock Research Monitor: ACHC, MD, and TVTY LONDON, UK / ACCESSWIRE / May 16, 2018 / If you want a free Stock Review on DVA sign up now at www.wallstequities.com/registration . Research reports have been ...
DENVER, May 16, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (DVA), and a leading provider of kidney care services in the United States, today celebrates its teammates (employees) who volunteered with Bridge of Life (BOL), a nonprofit organization founded by DaVita Inc., and the Syrian American Medical Society (SAMS) last month to screen Syrian refugees in Irbid, Jordan for hypertension, diabetes and kidney disease and provide health education.
Moody's Investors Service (Moody's) announced today that it assigned Baa3 ratings to DaVita Inc.'s incremental senior secured term loan A add-ons. There is no change to DaVita's existing ratings, including its Ba2 Corporate Family Rating, Ba2-PD Probability of Default Rating, Baa3 ratings on its other senior secured credit facilities and the Ba3 ratings on its unsecured notes.
DENVER , May 8, 2018 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA) and a leading provider of kidney care services in the United States , today announced its endorsement of ...
DENVER, May 7, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (DVA), a leading provider of kidney care services in the United States, today kicked off National Nurses Week by thanking its more than 18,000 nurses for the integral role each plays in helping patients with kidney disease have a better quality of life. Kidney care nurses spend a lot of time with their patients, as many patients receive in-center hemodialysis three times a week for up to four hours per treatment. In addition to delivering life-sustaining dialysis treatments, kidney care nurses have the opportunity to connect with patients on a deeper level.
The Denver-based company said it had net income of 98 cents per share. Earnings, adjusted to account for discontinued operations, came to $1.05 per share. The results topped Wall Street expectations. The ...
DENVER , May 3, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced results for the quarter ended March 31, 2018. Net income from continuing operations attributable to DaVita Inc. for the quarter ...
DENVER , May 2, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States , today announced it was recognized ...
Company adds Dr. Roer to deepen its clinical focus on integrated kidney care DENVER , May 1, 2018 /PRNewswire/ -- DaVita Kidney Care , a division of DaVita Inc. (NYSE: DVA), a leading provider in kidney ...
The program shows "how transplantation and dialysis can work together instead of operating in separate silos."
DENVER, April 27, 2018 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita Inc. (DVA) and a leading provider of kidney care services in the United States, today announced it has led the industry for the fourth year by meeting or exceeding Medicare standards in the Centers for Medicare & Medicaid Services (CMS) Five-Star Quality Rating System (Five-Star). The results mark DaVita's best quality performance in the program to date. "The entire kidney care community has come together through Five-Star to raise the bar on quality year over year," said Javier Rodriguez, CEO for DaVita Kidney Care.
There aren't many end-stage renal disease patients — it's less than 1 percent of the Medicare population — but they're expensive to insurers: Each patient's annual care cost an average $84,550 in 2013, about 7 percent of all Medicare fee-for-service spending.